Literature DB >> 508514

Absence of platelet monamine oxidase inhibition during amitriptyline or zimelidine treatment.

M A Reveley, V Glover, M Slander, A Coppen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1979        PMID： 508514      PMCID： PMC1429837          DOI： 10.1111/j.1365-2125.1979.tb04725.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN： 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  11 in total

1.  Nutritional and microbial effects on liver monoamine oxidase and serotonin in the chick.

Authors:  A W Phillips; H R Newcomb; F A Rupp; R Lachapelle
Journal:  J Nutr       Date:  1962-02       Impact factor: 4.798

2.  Inhibition of mouse brain monoamine oxidase by (+)-amphetamine in vivo.

Authors:  A L Green; M A el Hait
Journal:  J Pharm Pharmacol       Date:  1978-04       Impact factor: 3.765

3.  Deamination of beta-phenylethylamine by monoamine oxidase--inhibition by imipramine.

Authors:  J A Roth; C N Gillis
Journal:  Biochem Pharmacol       Date:  1974-09-15       Impact factor: 5.858

4.  In vivo inhibition of platelet MAO activity by tricyclic antidepressants.

Authors:  J L Sullivan; C Dackis; C Stanfield
Journal:  Am J Psychiatry       Date:  1977-02       Impact factor: 18.112

5.  Dopamine is a monoamine oxidase B substrate in man.

Authors:  V Glover; M Sandler; F Owen; G J Riley
Journal:  Nature       Date:  1977-01-06       Impact factor: 49.962

6.  Platelet MAO inhibition following tricyclic antidepressant therapy.

Authors:  J Davidson; M N Mcleod; M Linnoila; A A Kurland; H L White
Journal:  Am J Psychiatry       Date:  1978-05       Impact factor: 18.112

7.  Evidence for an endogenous inhibitor of platelet MAO in chronic schizophrenia.

Authors:  W H Berrettini; W H Vogel
Journal:  Am J Psychiatry       Date:  1978-05       Impact factor: 18.112

8.  Inhibition of monoamine oxidase by N-phenacyl-cyclopropylamine.

Authors:  R W Fuller; S K Hemrick; J Mills
Journal:  Biochem Pharmacol       Date:  1978       Impact factor: 5.858

9.  Clinical pharmacology of phenelzine.

Authors:  D S Robinson; A Nies; C L Ravaris; J O Ives; D Bartlett
Journal:  Arch Gen Psychiatry       Date:  1978-05

10.  Heterogeneity of human platelets. VII. Platelet monoamine oxidase activity in normals and patients with autoimmune thrombocytopenic purpura and reactive thrombocytosis: its relationship to platelet protein density.

Authors:  A J Friedhoff; J C Miller; S Karpatkin
Journal:  Blood       Date:  1978-02       Impact factor: 22.113
View more
  3 in total

1.  The effect of repeated doses of temazepam and nitrazepam on human psychomotor performance.

Authors:  G Tedeschi; A N Griffiths; A T Smith; A Richens
Journal:  Br J Clin Pharmacol       Date:  1985-10       Impact factor: 4.335

Review 2.  Zimelidine: a review of its pharmacological properties and therapeutic efficacy in depressive illness.

Authors:  R C Heel; P A Morley; R N Brogden; A A Carmine; T M Speight; G S Avery
Journal:  Drugs       Date:  1982-09       Impact factor: 9.546

Review 3.  Human platelet monoamine oxidase activity in health and disease: a review.

Authors:  M Sandler; M A Reveley; V Glover
Journal:  J Clin Pathol       Date:  1981-03       Impact factor: 3.411
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.